About the National Cancer Moonshot
June 2, 2016
This year, more than 1.6 million new cases of cancer will be diagnosed, and cancer will kill an estimated 600,000 Americans. Cancer research has reached an inflection point—a juncture where medical scientists are at the cusp of breakthroughs that could dramatically change those numbers. The National Cancer Moonshot initiative is being launched with $1 billion to accelerate that research.
Prevention and Cancer Vaccine Development
Speed up the development, evaluation and optimization of cancer vaccines
Early Cancer Detection
Invest in the development of minimally invasive screening assays that use genomic and proteomic technologies to detect cancer markers
Cancer Immunotherapy and Combination Therapy
Extend the early successes of immunotherapy; develop and test new combination therapies
Genomic Analysis of Tumor and Surrounding Cells
Reach a greater understanding of the genetic changes that occur within the cancer cell, in surrounding cells and in immune cells responding to the cancer.
Enhanced Data Sharing
Break down the barriers between institutions, including public and private sectors.
Oncology Center of Excellence
Develop a virtual Oncology Center of Excellence to expedite the development of novel combination products and to support an integrated approach to cancer prevention, new treatment tools and diagnostic devices and promote precision medicine.
Find new therapies for childhood cancers, intensify efforts to collect and analyze tumor specimens from the rarest of childhood cancers, and improve the sharing of clinical data.
Vice President’s Exceptional Opportunities in Cancer Research Fund
Establish competitive funding mechanism for high-risk, high-return research through partnerships with philanthropic organizations and representatives of the biotechnology and pharmaceutical industries.